These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31558856)

  • 1. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
    World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
    Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
    Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
    Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
    World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
    Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
    Li T; Sun G; Ye H; Song C; Shen Y; Cheng Y; Zou Y; Fang Z; Shi J; Wang K; Dai L; Wang P
    Br J Cancer; 2024 Sep; 131(5):883-894. PubMed ID: 38956246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
    Liu YQ; Chu LY; Yang T; Zhang B; Zheng ZT; Xie JJ; Xu YW; Fang WK
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35521959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
    Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
    Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
    Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
    Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
    Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
    Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
    EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.
    Kilic A; Schuchert MJ; Luketich JD; Landreneau RJ; Lokshin AE; Bigbee WL; El-Hefnawy T
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):199-204. PubMed ID: 18603076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor antigens that elicit a humoral immune response in the sera of Chinese esophageal squamous cell carcinoma patients by modified serological proteome analysis.
    Gao H; Zheng Z; Mao Y; Wang W; Qiao Y; Zhou L; Liu F; He H; Zhao X
    Cancer Lett; 2014 Mar; 344(1):54-61. PubMed ID: 24157810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of auto-quantified tumor-infiltrating lymphocytes and the prognostic value in adenocarcinoma of the esophagogastric junction, gastric adenocarcinoma, and esophageal squamous cell carcinoma.
    Dong H; Yao L; Fan J; Gao P; Yang X; Yuan Z; Zhang T; Lu M; Chen X; Suo C
    Aging (Albany NY); 2024 Jul; 16(13):11027-11061. PubMed ID: 38975889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
    Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
    J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
    Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
    EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.